α2 adrenergic receptor antag 
Welcome,         Profile    Billing    Logout  
 11 Companies  13 Products   13 Products   24 Diseases   117 Trials   6317 News 
160 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
idazoxan (RX 781094) / Houston Pharma
NCT05727189: A Study of Idazoxan in Healthy Participants

Recruiting
1
150
RoW
TR-01-XRR (1), R-Idazoxan HCL Extended Release (medium release rate) Tablet, TR-01-XRR (2), R-Idazoxan HCL Extended Release (faster release rate) Tablet, TR-01-XRR (3), R-Idazoxan HCL Extended Release (slower release rate) Tablet, TR-01-XRS, S-Idazoxan Extended Release Tablet, TR-01-XR, Racemic Idazoxan HCL Extended Release Tablet, TR-01-IR, Idazoxan HCL Immediate Release Tablet, Placebo, Matching Placebo Tablet
Terran Biosciences Australia Pty Ltd
Healthy
03/24
03/24
Validive (clonidine MBT) / Monopar Therap
2021-000999-11: Study comparing the efficacy and safety of a clonidine tablet that sticks to the gum to a placebo tablet to prevent severe inflammation of the mouth caused by radiation treatment in patients with cancer in the middle of the throat Estudio que compara la eficacia y la seguridad de una tableta de clonidina que se pega a la encía versus tableta de placebo para prevenir una inflamación severa de la boca causada por el tratamiento de radiación en pacientes con cáncer en el medio de la garganta

Not yet recruiting
2/3
260
Europe
Validive (Clonidine HCl mucoadhesive buccal tablet (MBT)), Muco-adhesive buccal tablet
Monopar Therapeutics Inc., Monopar Therapeutics Inc.
Chemoradiotherapy (CRT)-induced severe oral mucositis (SOM) in patients with oropharyngeal cancer (OPC) Mucositis oral severa (MOS) inducida por quimioradioterapia (QRT) en pacientes con cáncer orofaríngeo (COF), Severe inflammation of the mouth caused by radiation treatment in patients with cancer in the middle of the throat Inflamación severa de la boca causada por el tratamiento de radiación en pacientes con cáncer en el medio de la garganta, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
 
 
VOICE, NCT04648020 / 2021-000999-11: Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.

Terminated
2b
190
Europe, US
Clonidine HCl Mucoadhesive Buccal Tablet, Validive®, Placebo Mucoadhesive Buccal Tablet
Monopar Therapeutics, Monopar Therapeutics Inc.
Chemoradiotherapy-Induced Severe Oral Mucositis
05/23
05/23
maprotiline / Generic mfg.
2013-004881-33: Multicentre trial in to investigate the usage of antidepressant and antipsychotics (with / without approval) in patients at the age of children and adolescents Groß an gelegte, einfache offene klinische Studie mit mehreren teilnehmenden Prüfzentren zur Anwendung von Antidepressiva und Neuroleptika (mit /ohne Zulassung)

Ongoing
3
1000
Europe
Tablet, Abilify, Zyprexa, Leponex, Seroquel, Risperdal, Zeldox, Melneurin, Dipiperon, Saroten, Cipramil, Anafranil, Aponal, Cymbalta, Cipralex, Fluctin, Fevarin, Tofranil, Ludiomil, Remergil, Nortrilen, Paroxat, Zoloft, Stangyl, Trevilor
Universitätsklinikum Würzburg, Kompetenznetz TDM-KJP e.V., BfArM
therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
Teluron (terguride) / Pfizer, ErgoNex
2015-002586-39: Terguride Plus Symptomatic Therapy in Patients with Diffuse Cutaneous Systemic Sclerosis

Ongoing
3
148
Europe
Terguride, /, Tablet, METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL
medac GmbH, MEDAC GMBH, medac GmbH
Diffuse cutaneous systemic sclerosis (dcSSc), systemic sclerosis, Diseases [C] - Immune System Diseases [C20]
 
 
2009-017869-27: A dual-center, open-label Proof of Concept study to evaluate the efficacy of Terguride for the treatment of fibrosis in patients with systemic sclerosis.

Ongoing
2
7
Europe
Terguride, PR1,
University Hospital Zurich
Diffuse scleroderma
 
 
paliperidone extended release / Generic mfg.
ChiCTR-IPR-16009208: The safety of Paliperidone Extended-Release Tablets and Olanzapine in treating patients with schizophrenia

Recruiting
4
120
 
Paliperidone Extended-Release Tablets ;Olanzapine
The Seventh People's Hospital of Shaoxing City; the seventh people’s hospital of Shaoxing City, the seventh people’s hospital of Shaoxing City
schizophrenia
 
 
NCT04478838: "Extended" (Alternate Day) Antipsychotic Dosing

Recruiting
4
120
Canada
Risperidone, Risperdal, Olanzapine, Zyprexa, Apo-Olanzapine, Sandoz-Olanzapine, Invega Paliperidone
Centre for Addiction and Mental Health
Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy, Antipsychotic Agents
09/27
09/28
2006-005734-20: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Flexible Dose Paliperidone ER in the Treatment of Subjects with Schizoaffective Disorder

Ongoing
3
40
Europe
Paliperidone ER, R076477,
Janssen L.P.
Schizoaffective disorder
 
 
ChiCTR-TRC-12002273: Effects of paliperidone extended-release tablets (paliperidone ER) and olanzapine on metabolic profile, insulin resistance and beta-cell function in schizophrenic patients: a randomized 12-week study

Completed
N/A
80
 
paliperidone extended-release ;olanzapine
First Affiliated Hospital, College of Medicine, Zhejiang University; Level of the institution:, Key Medical Disciplines Funds in Zhejiang Province
Schizophrenia
 
 
ChiCTR-TRC-14004854: A randomized, controlled, multi-center clinical trial to study the treatment resistant schizophrenia (TRS) in Zhejiang province

Completed
N/A
200
 
Paliperidone Extended-Release Tablets ;Olanzapine
First Affiliated Hospital, Zhejiang University School of Medicine; None, self-financing
Schizophrenia
 
 
ChiCTR-TRC-14004452: The efficacy and safety of Paliperidone Extended-Release Tablets combined with sodium valproate in Bipolar disorder manic episode

Recruiting
N/A
200
 
PANSS ;Paliperidone Extended-Release Tablets combined with placebo ;Paliperidone Extended-Release Tablets combined with sodium valproate
First Affiliated Hospital, College of Medicine, Zhejiang University; First Affiliated Hospital, College of Medicine, Zhejiang University, National Natural Science Foundation (81301158)
Bipolar disorder
 
 
quetiapine / Generic mfg.
2007-004513-33: Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression

Ongoing
4
300
Europe
Dispersible tablet, Tablet, Lamictal, TillVal Folysra (Folic acid)
University of Oxford
Bipolar depression
 
 
ChiCTR2200061843: A 24-Week, Randomized, Open-Label, Haloperidol-Control Study to Evaluate the Efficacy of Quetiapine in Improving Social Cognitive Function of Patients with Schizophrenia

Completed
4
62
 
treatment with quetiapine ;treatment with haliperidol
Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Xi’An Janssen Pharmaceutical Ltd.
Schizophrenia
 
 
ChiCTR-TNRC-10001112: The study on clinical and biological characters of bipolar depression and the treatment scheme optimizing

Completed
4
640
 
Lithium, Sodium valproate, Lamotrigine, MECT, Sertraline, Citalopram, Escitalopram, venlafaxine, Quetiapine, Olanzapine, Risperidone, sulpiride
Guangzhou Scientific and Technological Bureau, Guangzhou Board of Health; Guangzhou first people's hospital, The Tackling Key Problems of Guangzhou Scientific and Technological Project
bipolar depressive disorder
 
 
ChiCTR-TRC-10000934: Pharmacogenomic study of schizophrenia

Completed
4
3000
 
Perphenazine 16-64 mg/d (N=250) or Haloperidol 6-20 mg/d (N=250) ;Risperidone 2-6mg/d ;Olanzapine 5-20 mg/d ;Quetiapine 400-750mg/d ;Aripiperazole 10~30 mg/d ;Ziprasidone 80-160 mg/d
The Sixth Hospital / Institute of Mental Health, Peking University; The Ministry of Science and Technology, The National High Technology Research and Development Program of China (863 program)
Schizophrenia
 
 
ChiCTR-IPR-16009475: The research of chronic insomnia clinical evaluation and optimization of treatment

Completed
4
100
 
alprazolam ;Zolpidem ;Trazodone ;Quetiapine
Shanghai Mental Health Center; Shanghai Mental Health Center, Shanghai science and technology committee
chronic insomnia
 
 
2004-003826-92: \"A Randomized, Parallel Group, Open Trial Examining the Safety, Efficacy and Tolerability of Fast Titration, 800mg/day by day 4, of Quetiapine Fumarate Compared to Standard Titration, 400mg/day by day 4, in the Treatment of Bipolar 1 Manic Episode.\"

Ongoing
4
150
Europe
Fumarato de quetiapina (Seroquel), Seroquel 25 mg comprimidos recubiertos con película Seroquel 100 mg comprimidos recubiertos con película Seroquel 200 mg comprimidos recubiertos con película, Seroquel 25 mg comprimidos recubiertos con película Seroquel 100 mg comprimidos recubiertos con película Seroquel 200 mg comprimidos recubiertos con película
AstraZeneca Farmacéutica Spain, S.A.
Tratamiento del Episodio Maníaco Bipolar Tipo I
 
 
2004-005078-22: Quetiapin: Zur Sicherheit, Verträglichkeit und zum Einfluss auf kognitive Funktionen bei Patienten/innen mit einer schizophrenen Psychose Quetiapine: safety and influence on cognitive functions in patients with schizophrenia: a single-trial event-related potential analysis

Ongoing
4
15
Europe
Seroquel®, 47291.00.00, 47291.01.00, 47291.02.00, Seroquel®, Seroquel®
Medical School of Hannover
Patients with schizophrenia, who are not in an acute state of psychosis at enrolment (PANSS score < 80) and who do not show criteria of moderate depression, but may show depression-like symptoms corresponding to negative symptoms of schizophrenia (MADRS score ≤XXX). ICD classification code : F 20.0, 20.1, 20.2, 20.3, 20.5, 20.6
 
 
2004-002608-13: Pragmatic Randomised Control Trial of Quetiapine for psychosis in Parkinson’s Disease

Ongoing
4
60
Europe
Seroquel, Seroquel, Seroquel
King’s College London & King’s College Hospital
Parkinson\'s Disease with psychosis
 
 
2005-005072-32: Is it possible to modify the course of manic relapse? A pilot study of the effectiveness of quetiapine in preventing the development of manic episodes in Bipolar Disorder.

Ongoing
4
50
Europe
Quetiapine, Seroquel 100mg, Seroquel 150mg, Seroquel 200mg, Seroquel 300mg, Seroquel 100mg, Seroquel 150mg, Seroquel 200mg, Seroquel 300mg
Kings College London (IOP) / South London and Maudsley NHS Trust (Co-sponsorship)
Bipolar Disorder
 
 
2006-001317-15: BALANCE 2: Bipolar disorder:Antidepressant/Lamotrigine/ANtipsychotic Comparative Evaluation

Ongoing
4
630
Europe
Selective Serotonin Reuptake Inhibitors, SSRI, Quetiapine, Lamotrigine, Quetiapine, Lamotrigine
University of Oxford
Bipolar depression.
 
 
2006-002342-11: Multicenter study of neurotransmitters and neuropeptides in schizophrenia: A multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffering from schizophrenia treated with quetiapine (Seroquel®).

Ongoing
4
22
Europe
Seroquel 25, Seroquel 100, Seroquel 300, Seroquel 25, Seroquel 100, Seroquel 300, Seroquel 25, Seroquel 100, Seroquel 300
Klinikum Fulda gAG
Patients have to fulfill the diagnostic criteria of a schizophrenia according to DSM-IV.
 
 
2007-000579-40: Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study

Ongoing
4
34
Europe
Seroquel, Haloperidol Hexal, Seroquel, Haloperidol Hexal, Seroquel, Haloperidol Hexal
Charité Universitätsmedizin Berlin
Schizophrenia
 
 
2007-004528-19: Electrophysiological measurement of anterior cingulate cortex (ACC) function in schizophrenic patients treated with Seroquel® or Fluanxol®

Ongoing
4
50
Europe
Seroquel (Quetiapine), Fluanxol (Flupentixol), Seroquel, Fluanxol, Seroquel, Fluanxol
University of Wuerzburg
schizophrenia (295.10, 295.20, 295.30, 295.90 according to Diagnostic and Statistical Manual of Mental Disorders- Fourth Edition (DSM-IV)
 
 
2007-004897-26: Memantine for the Long Term Management of Neuropsychiatric Symptoms in Alzheimer\'s disease - MAIN-AD

Ongoing
4
300
Europe
Memantine, Risperidone, Ebixa, Risperdal, Zyprexa, Seroquel, Haloperidol (proprietary), Ebixa, Risperdal, Zyprexa, Seroquel, Haloperidol (proprietary)
King\'s College London, North Essex Partnership NHS Foundation Trust
Alzheimer\'s disease
 
 
2013-003460-31: The effect of low doses of mirtazapine and quetiapine on sleep and daytime functioning.

Ongoing
4
25
Europe
mirtazapine, quetiapine, n/a,
GGZ-Drenthe, GGZ-Drenthe
Insomnia
 
 
2016-001637-27: Lithium versus Quetiapine in Treatment Resistant Depression.

Ongoing
4
276
Europe
Lithium carbonate, Quetiapine, Lithium citrate, Tablet, Syrup
South London and Maudsley NHS Foundation Trust, King's College London, National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme
Treatment resistant major depressive disorder (single episode or recurrent). Treatment resistant depression, defined as failure to respond to two or more adequate doses of antidepressant in the current episode, Treatment resistant depression: where the person with depression has not responded adequately to two or more antidepressants given in the current episode of depression., Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
2017-002406-12: HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A study comparing continuation versus discontinuation/dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis HAMLETT. Handling Antipsychotic Medication: Lange termijn evaluatie van specifiek toegepaste medicatie. Vergelijking tussen het doorgaan met antipsychotische medicatie bij patiënten die hersteld zijn van eerste psychotische episode en vroegtijdig afbouwen/stoppen.

Not yet recruiting
4
512
Europe
RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE, CID5073, CID135398745, CID5002, CID60795, CID3559, CID5355, CID115237, CID16362, CID213046, CID135398737, CID2159, CID5467, CID60149, CID667467, CIS5311507, Tablet, RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE
University Medical Center Groningen, ZonMw
HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation. HAMLETT vergelijkt de reguliere behandeling van patiënten in remissie na een eerste psychotische episode zoals beschreven in de richtlijnen, namelijk het continueren van antipsychotica voor minstens 1 jaar, met het vroegtijdig afbouwen/stoppen met medicatie., HAMLETT compares continuation versus early discontinuation of antipsychotic medication in patients who have recovered from their first episode of psychosis. HAMLETT vergelijkt de reguliere behandeling van patiënten die hersteld zijn van een eerste psychose, namelijk minimaal 1 jaar antipsychotica gebruiken, met vroegtijdig afbouwen/stoppn met medicatie, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
2017-004602-17: Digital Medicine System

Not yet recruiting
4
60
Europe
DM-Aripiprazole, DM-Olanzapine, DM- Quetiapine, DM-Risperidone, Tablet, Aripiprazole, Olanzapine, Quetiapine, Risperidone
Otsuka Pharmaceutical, Otsuka Pharmaceutical
Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis, Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
ChiCTR1800014755: Study on individualized optimal treatment for antipsychotic drugs

Recruiting
4
2000
 
Risperidone ;Olanzapine ;Aripiperazole ;Quetiapine
国家科技部; Peking University Sixth Hospital, The Ministry of Science and Technology
Schizophrenia
 
 
LQD, NCT03004521: Lithium Versus Quetiapine in Treatment Resistant Depression

Recruiting
4
276
Europe
Quetiapine, Lithium
King's College London, University of Oxford, Newcastle University, Oxford Health NHS Foundation Trust, Northumberland, Tyne and Wear NHS Foundation Trust, South London and Maudsley NHS Foundation Trust, Tees, Esk and Wear Valleys NHS Foundation Trust, Sussex Partnership NHS Foundation Trust, Avon and Wiltshire Mental Health Partnership NHS Trust
Depressive Disorder, Treatment-Resistant
04/21
08/21
NCT04446234: Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building

Not yet recruiting
4
350
RoW
Risperidone, Aripiprazole, Ziprasidone, Amisulpride, Quetiapine
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine
Schizophrenia
12/22
12/22
NCT04513314: Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium

Withdrawn
4
20
NA
Valproate, Depakote, Valproic acid, Quetiapine, seroquel, Standard of Care, Hospital Protocol
University of Miami
Covid19, Hyperactive Delirium, Pneumonia, Viral
03/23
03/23
ChiCTR2100049426: A randomized and controlled study of ruracidone in the treatment of bipolar depression in adolescents and early adulthood

Not yet recruiting
4
60
 
treatment with lurasidone ;treatment with quetiapine
Beijing AnDing Hospital, Capital Medical University; Beijing AnDing Hospital, Capital Medical University, Beijing Hospital Authority
bipolar disorder
 
 
TraQ, NCT05085808: RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium

Not yet recruiting
4
30
US
Trazodone, Desyrel, Quetiapine, Seroquel, Placebo
University of Southern California
Delirium, Morality, Quality of Life, Psych, Treatment Side Effects
07/26
12/26
ChiCTR2200064086: The clinical efficacy of Quetiapine in the treatment of PD hallucinations and the mechanism of electrophysiology and brain imaging

Not yet recruiting
4
30
 
Quetiapine ;none ;none
Nanjing Brain Hospital; Nanjing Brain Hospital, crosswise tasks
Parkinson's disease with hallucinations
 
 
CAMELOT, NCT05590637: Comparing Antipsychotic Medications in LBD Over Time

Recruiting
4
94
US
Pimavanserin, Nuplazid, Quetiapine, Seroquel
The University of Texas Health Science Center at San Antonio, Alzheimer's Association
Parkinson's Disease Psychosis, Dementia With Lewy Bodies
08/25
02/26
NCT05741502: An Exploratory Analysis of Immune and Inflammatory Response Associated with Clozapine

Recruiting
4
60
US
Clozapine, Antipsychotics,Other (non-Clozapine), Including Olanzapine, Risperidone, Paliperidone, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, and all Typical antipsychotics
Ohio State University
Treatment-resistant Schizophrenia
03/26
06/26
NCT05737511: Efficacy of Hydroxyzine for Patients With Panic Disorder

Not yet recruiting
4
80
NA
Hydroxyzine, Atarax, Vistaril, Escitalopram Oxalate, citalopram, fluoxetine, fluvoxamine, paroxetine, paroxetine CR, sertraline, venlafaxine XR,, Alprazolam, clomipramine, clonazepam, diazepam, imipramine, lorazepam, mirtazapine, reboxetine, Bupropion SR, divalproex, duloxetine, gabapentin, levetiracetam, milnacipran, moclobemide, olanzapine, phenelzine, quetiapine, risperidone, tranylcypromine
Sultan Qaboos University
Panic Disorder
12/26
12/26
2005-003251-13: Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study

Ongoing
3
40
Europe
Seroquel, Seroquel 25 mg, Seroquel 100 mg, Seroquel 150 mg, Seroquel 200 mg, Seroquel 300 mg, Seroquel 25 mg, Seroquel 100 mg, Seroquel 150 mg, Seroquel 200 mg, Seroquel 300 mg
AstraZeneca UK Ltd
Depression
 
 
2009-011253-40: Paroxetine or Quetiapine in Addition to Mood Stabilizers in Bipolar Depression

Ongoing
3
40
Europe
DAPAROX*28CPR RIV 20MG PVC/PE/, SEROQUEL*60CPR RIV 100MG, DAPAROX*28CPR RIV 20MG PVC/PE/, SEROQUEL*60CPR RIV 100MG
AZIENDA SANITARIA OSPEDALIERA \"S. GIOVANNI BATTISTA DI TORINO\"
Major Depressive Episode in Bipolar Disorder
 
 
2010-021142-21: ?Alteraciones del sueño en pacientes con depresión mayor resistente al tratamiento con inhibidores selectivos de la recaptación de serotonina: ensayo clínico, aleatorizado, abierto, de grupos paralelos sobre la eficacia de Quetiapina de liberación prolongada vs Sales de Litio?

Ongoing
3
32
Europe
SEROQUEL PROLONG 50 mg comprimidos de liberación prolongada, PLENUR comprimidos de liberación modificada, SEROQUEL PROLONG 50 mg comprimidos de liberación prolongada, PLENUR comprimidos de liberación modificada
Fundación Institut de Recerca de l\' Hospital de la Santa Creu i Sant Pau
Depresión mayor resistente a Inhibidores Selectivos de la Recaptación de serotonina,Código de clasificación de la CIE : F-33
 
 
2016-004117-27: CONTROLLED, DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL FOR PROPHILAXIS OF POSOPERATIVE DELIRIUM IN HIGH RISK SURGICAL PATIENTS WITH QUETIAPINE. ENSAYO CLÍNICO CONTROLADO, DOBLE CIEGO Y ALEATORIZADO PARA LA PROFILAXIS CON QUETIAPINA DEL DELIRIO POSTOPERATORIO EN PACIENTES QUIRÚRGICOS DE RIESGO

Not yet recruiting
3
350
Europe
Capsule, Quetiapina NORMON 25 mg comprimidos recubiertos con peícula EFG
IBSAL (Instituto de Investigación Biomédica de, IBSAL, GRUPO DE RECUPERACION MULTIMODAL ESPAÑOL
Postoperative delirium in high risk surgical patients. Delirio postoperatorio en pacientes quirúrgicos de alto riesgo., Postoperative delirium. Delirio postoperatorio., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
NCT05690698: Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium

Completed
3
100
RoW
Quatiapine, Haloperidol
Alexandria University, Suez Canal University, Gezira University
Hyperactive Delirium
07/23
07/23
NCT06482554: Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Recruiting
3
80
US
Lumateperone 42 mg, Lumateperone, Risperidone 2 mg, olanzapine; quetiapine; ziprasidone; aripiprazole
Louisiana State University Health Sciences Center Shreveport
Apathy, Schizophrenia, Schizophrenia; Psychosis
12/26
12/26
NCT06333990: Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)

Recruiting
3
146
US
Quetiapine Fumarate, Seroquel, TAU, Treatment As Usual
Foundation for Advancing Veterans' Health Research, The University of Texas Health Science Center at San Antonio, Biomedical Research Institute of New Mexico
Mild Traumatic Brain Injury
06/28
06/28
INTENSIFY BD, NCT05973786: The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Recruiting
3
418
Europe
Escitalopram, ATC code: N06AB10, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04
Dr. Inge Winter, Universität Münster
Bipolar Depression
06/26
06/26
INTENSIFY, NCT05603104: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

Recruiting
3
1254
RoW
Clozapine, ATC code: N05AH02, Esketamine Nasal Product, ATC code: N06AB10, Escitalopram, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04, Second-line Antidepressants, Second-line Antipsychotics, Ketamine Hydrochloride, N01AX03, Esketamine hydrochloride, N015X14
Dr. Inge Winter, Universität Münster
Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression
06/26
06/26
2020-006062-36: A Phase II/III, randomized, 4-week, placebo-controlled study, designed to determine the safety, tolerability, and efficacy of evenamide (NW-3509) in patients with chronic schizophrenia.

Ongoing
2/3
196
Europe, RoW
Evenamide, NW3509, Capsule, hard
Newron Pharmaceuticals S.p.A., NEWRON PHARMACEUTICALS SPA, Newron Pharmaceuticals S.p.A, Newron Pharmaceuticals S.p.A., Newron Pharmaceuticals S.p.A
Chronic schizophrenia, Chronic schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
2021-001333-38: Clinical trial to study the effect of an already authorized drug on other pathologies by administering it to people with a recent diagnosis of schizophrenia. Ensayo clínico para estudiar el efecto que tiene un fármaco ya autorizado en otras patologías administrándolo en personas con reciente diagnóstico de esquizofrenia.

Not yet recruiting
2/3
50
Europe
VORTIOXETINA, HALOPERIDOL, Pimozida, Olanzapina, Risperidona, Chlorpromazine, Thioridazine, Quetiapine, Ziprasidone, aripiprazole, N06AX26, N05AD01, NO5AG02, NO5A H03, NO5AX08, N05AA01, N05AC02, N05AH04, N05AE04, N05AX12, Tablet, Capsule, hard, BRINTELLIX
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI), Consejería de salud
Early schizophrenia Esquizofrenia temprana, Newly evolving schizophrenia Esquizofrenia de reciente evolución, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
MEL-QUE, NCT06062953: Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients with Psychiatric Disorders and Comorbid Insomnia

Recruiting
2/3
255
Europe
Melatonin, Quetiapine, Placebo
Lone Baandrup, Danish Center for Sleep Medicine, Region Capital Denmark, Copenhagen Trial Unit, Center for Clinical Intervention Research, Mental Health Services in the Capital Region, Denmark
Psychiatric Disorders, Insomnia
02/29
02/29
ACTRN12622001532796: A multicentre, cluster randomised, double cross over pragmatic clinical trial comparing the safety and efficacy of enteral olanzapine with quetiapine in critically ill patients with hyperactive delirium

Not yet recruiting
2
1200
 
Royal Melbourne Hospital, The Australian and New Zealand Intensive Care Foundation
critical illness, hyperactive delirium
 
 
ACTRN12624001075572: A single centre pilot randomised controlled trial of enteral Guanfacine vs Quetiapine for agitated delirium in patients in the intensive care unit

Recruiting
2
36
 
Austin Hospital, Austin Health
Agitated delirium
 
 
2006-004783-31: A Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, MultiCentre, Phase IIa Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of AZD3480 in Schizophrenic Patients on Stable Antipsychotic Monotherapy with quetiapine, risperidone or olanzapine

Ongoing
2
50
Europe
AZD3480,
AstraZeneca AB
Schizophrenia
 
 
NCT05793632: Quetiapine in Prevention of Delirium

Completed
2
90
RoW
Quetiapine
Ain Shams University
Delirium
04/23
04/23
QOSA, NCT05303935: Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea

Completed
2
15
RoW
Quetiapine 50 MG, Seroquel, Placebo, Sugar pill
Flinders University
Sleep Apnea, Obstructive
04/23
04/23
NCT04521478 / 2019-004264-21: A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Completed
2
389
Europe, Canada, Japan, US, RoW
BI 1358894, Placebo, Quetiapine
Boehringer Ingelheim
Depressive Disorder, Major
01/24
02/24
NCT04280965: Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

Completed
1
28
US
Quetiapine Fumarate, Seroquel, Standard of care meducations
The University of Texas Health Science Center at San Antonio, South Central MIRECC
Post Traumatic Stress Disorder
04/22
10/22
NCT04950868: The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression

Active, not recruiting
1
22
Canada
Quetiapine
Verinder Sharma
Postpartum Depression
06/25
06/25
NCT05402111: A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

Completed
1
31
US
SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Schizophrenia
09/23
09/23
NCT05542264: A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

Completed
1
19
US
SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Schizophrenia
02/24
02/24
NCT05240261: Sleep Disorders in Chronic Kidney Disease Patients

Not yet recruiting
1
60
NA
Quetiapine
Assiut University
Chronic Kidney Diseases
05/24
12/24
NCT06546358: Quetiapine Versus Trazadone in Women With Postpartum Depression

Not yet recruiting
1
50
Canada
Trazodone, Teva-Trazadone, Quetiapine, Quetiapine Fumarate
Lawson Health Research Institute
Postpartum Depression
09/25
12/25
ChiCTR2100054147: Correlation between dopamine receptor gene polymorphism and clinical effect of bipolar depressive episode

Not yet recruiting
1
180
 
Lamotrigine ;Quetiapine ;Bupropion ;None
Jiaxing Kangci Hospital; Jiaxing Kangci Hospital, Provincial Health Commission, Jiaxing Kangci Hospital, self-funded
Bipolar depression
 
 
ChiCTR-TRC-14004814: A randomized controlled trial of repetitive transcranial magnetic stimulation combined with quetiapine in the first-episode bipolar II depressive episode

Completed
N/A
60
 
quetiapine+false TMS treatment ;quetaipine+rTMS high-frequency ;quetaipine+rTMS low-frequency
The First Affiliated Hospital, Zhejiang University; The First Affiliated Hospital, Zhejiang University, Scientific research expenses
Bipolar II depressive episode
 
 
ChiCTR-IPR-16008425: Efficacy of quetiapine in behavioral and psychological symptoms of Alzheimer's disease patients

Not yet recruiting
N/A
120
 
Quetiapine ;Memantine
Changning Mental Health Center; Changning Mental Health Center, Key program of the Changning Science and Technology Committee
Alzheimer's disease
 
 
ChiCTR-COC-17011401: A study of gut microbiota, immunology, Imageology in patients with bipolar disorder

Recruiting
N/A
200
 
quetiapine monotherapy
First Affiliated Hospital, Zhejiang University School of Medicine; First Affiliated Hospital, Zhejiang University School of Medicine, Provincial Natural Science Foundation
Bipolar disorder
 
 
NCT06200584: Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics

Completed
N/A
140
RoW
Risperidone, neuroleptics, Olanzapine, Quetiapine, Risperidone and Vitamin D and Vitamin E, vitamin, Olanzapine and Vitamin D and Vitamin E, Quetiapine and Vitamin D and Vitamin E
Dr Rabia Arshad
Antipsychotics and Neuroleptics Toxicity
06/21
06/21
NCT05098353: Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control

Recruiting
N/A
30
RoW
Quetiapine, Quetiapine - impulsivity
Federal Stare Budgetary Scientific Institution, Mental Health Research Center, Kazan State Medical University, Federal State Budgetary Institution V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, Saint-Petersburg, Russia
Bipolar Affective Disorder
11/21
12/21
NCT04209166: A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features

Recruiting
N/A
780
RoW
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors), SSRIs/SNRIs+Mood Stabilizer, SSRIs/SNRIs+Quetiapine, Usual Treatment
Shanghai Mental Health Center, Air Force Military Medical University, China, Guangzhou Psychiatric Hospital, Dalian Seventh People's Hospital, Wuhan Union Hospital, China, Shanghai Jiao Tong University School of Medicine
Major Depressive Disorder
10/22
10/22
SWITCH, NCT04312503: Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"

Completed
N/A
95
Europe
Lurasidone, Latuda, aripiprazole, olanzapine, quetiapine or risperidone
Aziende Chimiche Riunite Angelini Francesco S.p.A
Schizophrenia
10/22
10/22
ChiCTR2200059660: Clinical study of single intravenous injection of esmketamine combined with an oral antidepressant in the treatment of depressive disorde

Not yet recruiting
N/A
80
 
Use 0.25mg/kg ESM ketamine injection and physiological test Dilute saline injection to 50ml and drip intravenously for 40 minutes; Quetiapine fumarate (SRI Kang) was used as a synergist at a dose of 25-400 mg per day
Beijing Chaoyang Hospital; Beijing Chaoyang Hospital, self-raised
Depression
 
 
NCT05801289: Quetiapine as Prophylaxis for Delirium in CABG

Recruiting
N/A
60
RoW
Quetiapine, Seroquel
Ain Shams University
Delirium
04/23
04/23
NCT05840861: Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective Disorders

Recruiting
N/A
59
RoW
Vortioxetine, Quetiapine
Central South University
Major Depressive Disorder, Bipolar Disorder
08/23
09/23
NCT05833399: Correlation of Genetic Variations With Clinical Response in Substance Use Disorder

Recruiting
N/A
200
RoW
Quetiapine, olanzapine, mirtazapine, carbamazepine, sertraline, amitriptyline, chlorpromazine and risperidone, Seroquel, Olapex, Remeron, Tegretol, Moodapex, Tryptizol, Neurazine and Apexidone.
Alexandria University
Substance Use Disorders, Substance Dependence
03/24
12/24
ChiCTR2400083720: Effect of value orientation on brain activation in depressive patients with psychotic symptoms

Recruiting
N/A
60
 
Sertraline and quetiapine plus value-oriented short-term psychotherapy; Sertraline and quetiapine
The Second Affiliated Hospital of Xinxiang Medical College; The Second Affiliated Hospital of Xinxiang Medical College, Henan Province key research and development project
depression with psychotic symptoms
 
 
ChiCTR2100054169: Early effects of rTMS on bipolar depression by the modulation of prefrontal-amygdala/striatal brain network

Not yet recruiting
N/A
120
 
Combination therapy with rTMS and quetiapine ;Combination therapy with sham stimulation and quetiapine
Shenzhen Kangning Hospital; Shenzhen Kangning Hospital, Shenzhen Kangning Hospital
Bipolar depression
 
 
NCT06581302: Magnetic Seizure Therapy for Psychotic Disorders

Not yet recruiting
N/A
50
RoW
Magnetic seizure therapy by Magnetic stimulator, Seizure therapy, Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc), antipsychotics
Shanghai Jiao Tong University School of Medicine
Psychotic Disorders
12/25
12/25
PRHDTDCSTMDE, NCT05498441: Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive Episode

Recruiting
N/A
120
RoW
High-Definition Transcranial Direct Current Stimulation (HD-tDCS), Antipsychotics, mood stabilizers, etc.
Jiangsu Province Nanjing Brain Hospital
Major Depressive Episode
12/24
12/24
ChiCTR2300075440: Researches on the clinical curative effect of Yin-enching and Heat-cleaning on the treatment of the prodromal phases of bipolar disorder

Not yet recruiting
N/A
94
 
Traditional Chinese medicine formula granules+Imitated tablets of quetiapine fumarate; Chinese herbal placebo+quetiapine fumarate tablets
Beijing Anding Hospital,Capital Medical University; Beijing Anding Hospital,Capital Medical University, Beijing Municipal Administration of Hospital Incubating Program
the prodromal phases of bipolar disorder
 
 
TQDelirium, NCT05307003: Trazodone vs. Quetiapine for the Treatment of ICU Delirium

Recruiting
N/A
60
US
Trazodone, Desyrel, Quetiapine, Seroquel
University of Southern California
Delirium, Delirium of Mixed Origin, Delirium, Sepsis Associated, Delirium in Old Age, Delirium Confusional State, Psych, Morality, Treatment Side Effects
08/25
12/25
NCT04728581: Improving Sleep After TKA Using Mirtazapine and Quetiapine

Not yet recruiting
N/A
165
Europe
Mirtazapine, Quetiapine, Placebo
St. Anna Ziekenhuis, Geldrop, Netherlands
Osteo Arthritis Knee, Insomnia
05/26
01/27
NCT03449472: Bariatric Surgery and Pharmacokinetics of Quetiapine

Recruiting
N/A
12
Europe
Quetiapine, Quetiapine fumarate
Norwegian University of Science and Technology, St. Olavs Hospital, Volvat Medisinsk Senter Stokkan, Namsos Hospital, Alesund Hospital
Obesity, Morbid
10/26
10/26
CLASS-BD, NCT05480150: Chinese Longitudinal and Systematic Study of Bioplar Disorder

Recruiting
N/A
10000
RoW
Escitalopram Oxalate Tablets, Lexapro, Quetiapine Fumarate Tablets, Seroquel, Lurasidone, Latuda
First Affiliated Hospital of Zhejiang University
Major Depressive Disorder, Bipolar Disorder, Mixed, Affective; Disorder, Organic
12/26
12/26
ACTRN12616001227482: Thyroid tests in people who are taking quetiapine.

Recruiting
N/A
20
 
PathWest Laboratory Medicine, PathWest Laboratory Medicine
Mental health disorders, Schizophrenia, Bipolar disorder, Anxiety
 
 
ACTRN12616001242415: Thyroid tests in people who will be taking quetiapine.

Recruiting
N/A
20
 
PathWest Laboratory Medicine, PathWest Laboratory Medicine
Psychosis, treated with quetiapine, Mood disorders, treated with quetiapine, Agitation, treated with quetiapine
 
 
quetiapine extended-release / Generic mfg.
APQ-TRD, NCT04936126: Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression

Recruiting
4
150
RoW
Quetiapine, Amantadine, Pramipexole
All India Institute of Medical Sciences, Bhubaneswar, Indian Council of Medical Research
Treatment Resistant Depression
07/24
09/24
SMART-BD, NCT06433635: Sequential Multiple Assignment Randomized Trial for Bipolar Depression

Not yet recruiting
4
2726
Canada, US
Cariprazine, Vraylar, Aripiprazole/Escitalopram combination, Abilify/ Lexapro, Quetiapine, Seroquel, Lurasidone, Latuda
Massachusetts General Hospital, Patient-Centered Outcomes Research Institute
Bipolar I Disorder, Depression
02/30
02/30
C-SAPP, NCT04373317: Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Recruiting
4
358
US
Pimavanserin, Quetiapine
VA Office of Research and Development
Parkinson's Disease Psychosis
10/25
08/26
NCT03465787: A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia

Completed
3
210
RoW
Lurasidone HCL 160 mg, Quetiapine XR 600 mg
Bukwang Pharmaceutical
Schizophrenia
10/22
10/22
SEP361-304, NCT04115319 / 2019-002259-40: A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

Completed
3
475
Europe, US, RoW
SEP363856, quetiapine XR, Seroquel XR
Otsuka Pharmaceutical Development & Commercialization, Inc.
Schizophrenia
12/22
12/22
NCT04513912 / 2020-000341-14: A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Completed
3
757
Europe, Canada, US, RoW
Seltorexant, Matching placebo to Seltorexant, Quetiapine XR, Matching placebo to Quetiapine XR
Janssen Research & Development, LLC
Depressive Disorder, Major
10/23
10/23
ChiCTR2200066465: Bioequivalence of Quetiapine Fumarate Extended-release Tablets (Fasting /Feeding) in Healthy Human Body: a Randomized Cross-Over Controlled Trial

Not yet recruiting
1
40
 
In the morning of period I, participants received a single dose of test preparation after an overnight fast. In the period Ⅱ, participants crossed a single dose of reference preparation according to the randomized grouping table. ;In the morning of period I, participants received a single dose of reference preparation after an overnight fast. In the period Ⅱ, participants crossed a single dose of test preparation according to the randomized grouping table. ;In the morning of period I, participants received a single dose of test preparation after a high fat meal. In the period Ⅱ, participants crossed a single dose of reference preparation according to the randomized grouping table. ;In the morning of period I, participants received a single dose of reference preparation after a high fat meal. In the period Ⅱ, participants crossed a single dose of test preparation according to the randomized grouping table.
Xiangya Boai Rehabilitation Hospital; Europharm Laboratoires Co., Ltd., Europharm Laboratoires Co., Ltd.
Pharmacokinetics and Bioequivalence Study in human
 
 
NCT00710918: Quetiapine Compared With Placebo in the Management of Fibromyalgia

Recruiting
N/A
42
US
quetiapine, Seroquel XR, Placebo
East Tennessee State University Research Foundation
Fibromyalgia
06/11
12/11
mirtazapine / Generic mfg.
2006-003194-27: mirtazapine versus placebo in functional dyspepsia: a randomized, double-blind, placebo-controlled trial

Ongoing
4
60
Europe
mirtazapine, Orodispersible tablet, Remergon Soltab 15 mg
University Hospitals KU Leuven
functional dyspepsia diagnosed according to international consensus criteria ("Rome II criteria")
 
 
2009-016953-16: Depressions-Spektrums-Störung und differenzielle Effekte neuerer Antidepressiva auf die Verkehrssicherheit

Ongoing
4
120
Europe
Cipralex, Solvex, Remergil, Elontril, Valdoxan, Tablet, Cipralex, Solvex, Remergil, Elontril, Valdoxan
Inn-Salzach-Klinikum gGmbH
Spectrum of depressive diseases, ICD-10: F32.x, F33.x
 
 
ChiCTR-TRC-13003161: Clinical trials of antidepressant mirtazapine for the treatment of functional dyspepsia patients with weight loss

Completed
4
45
 
Group A is treated with conventional therapy during 8 weeks ;Group B is treated with conventional therapy in combination with Paroxetine during 8 weeks ;Group C is treated with conventional therapy in combination with Mirtazapine during 8 weeks
Guangzhou Nansha Central Hospital, Guangzhou First People's Hospital Affiliated to Guangzhou Medical College; Guangzhou Nansha Central Hospital, Guangzhou First People's Hospital Affiliated to Guangzhou Medical University, Self-funding
Functional Dyspepsia with Weight loss
 
 
2014-004862-89: The effect of mirtazapine (REMERGON®) an tetracyclic antidepressant on gastric movements and satiation in healthy subjects

Ongoing
4
30
Europe
mirtazapine, Film-coated tablet, REMERGON
KULeuven, KuLeuven
Functional Dyspepsia, the presence of dyspepsia in patients from which the cause of the gastric symptoms is unknown ( not organic nor metabolic), Diseases [C] - Digestive System Diseases [C06]
 
 
2004-002788-25: Hippocampal volume in young adults with moderate to severe depression before and after combined antidepressant therapy

Ongoing
4
160
Europe
Trevilor retard, Remergil Soltab, VENLA,
Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg
moderate to severe depression (episodes and recurrent diseases)
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
idazoxan (RX 781094) / Houston Pharma
NCT05727189: A Study of Idazoxan in Healthy Participants

Recruiting
1
150
RoW
TR-01-XRR (1), R-Idazoxan HCL Extended Release (medium release rate) Tablet, TR-01-XRR (2), R-Idazoxan HCL Extended Release (faster release rate) Tablet, TR-01-XRR (3), R-Idazoxan HCL Extended Release (slower release rate) Tablet, TR-01-XRS, S-Idazoxan Extended Release Tablet, TR-01-XR, Racemic Idazoxan HCL Extended Release Tablet, TR-01-IR, Idazoxan HCL Immediate Release Tablet, Placebo, Matching Placebo Tablet
Terran Biosciences Australia Pty Ltd
Healthy
03/24
03/24
Validive (clonidine MBT) / Monopar Therap
2021-000999-11: Study comparing the efficacy and safety of a clonidine tablet that sticks to the gum to a placebo tablet to prevent severe inflammation of the mouth caused by radiation treatment in patients with cancer in the middle of the throat Estudio que compara la eficacia y la seguridad de una tableta de clonidina que se pega a la encía versus tableta de placebo para prevenir una inflamación severa de la boca causada por el tratamiento de radiación en pacientes con cáncer en el medio de la garganta

Not yet recruiting
2/3
260
Europe
Validive (Clonidine HCl mucoadhesive buccal tablet (MBT)), Muco-adhesive buccal tablet
Monopar Therapeutics Inc., Monopar Therapeutics Inc.
Chemoradiotherapy (CRT)-induced severe oral mucositis (SOM) in patients with oropharyngeal cancer (OPC) Mucositis oral severa (MOS) inducida por quimioradioterapia (QRT) en pacientes con cáncer orofaríngeo (COF), Severe inflammation of the mouth caused by radiation treatment in patients with cancer in the middle of the throat Inflamación severa de la boca causada por el tratamiento de radiación en pacientes con cáncer en el medio de la garganta, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
 
 
VOICE, NCT04648020 / 2021-000999-11: Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.

Terminated
2b
190
Europe, US
Clonidine HCl Mucoadhesive Buccal Tablet, Validive®, Placebo Mucoadhesive Buccal Tablet
Monopar Therapeutics, Monopar Therapeutics Inc.
Chemoradiotherapy-Induced Severe Oral Mucositis
05/23
05/23
maprotiline / Generic mfg.
2013-004881-33: Multicentre trial in to investigate the usage of antidepressant and antipsychotics (with / without approval) in patients at the age of children and adolescents Groß an gelegte, einfache offene klinische Studie mit mehreren teilnehmenden Prüfzentren zur Anwendung von Antidepressiva und Neuroleptika (mit /ohne Zulassung)

Ongoing
3
1000
Europe
Tablet, Abilify, Zyprexa, Leponex, Seroquel, Risperdal, Zeldox, Melneurin, Dipiperon, Saroten, Cipramil, Anafranil, Aponal, Cymbalta, Cipralex, Fluctin, Fevarin, Tofranil, Ludiomil, Remergil, Nortrilen, Paroxat, Zoloft, Stangyl, Trevilor
Universitätsklinikum Würzburg, Kompetenznetz TDM-KJP e.V., BfArM
therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
Teluron (terguride) / Pfizer, ErgoNex
2015-002586-39: Terguride Plus Symptomatic Therapy in Patients with Diffuse Cutaneous Systemic Sclerosis

Ongoing
3
148
Europe
Terguride, /, Tablet, METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL
medac GmbH, MEDAC GMBH, medac GmbH
Diffuse cutaneous systemic sclerosis (dcSSc), systemic sclerosis, Diseases [C] - Immune System Diseases [C20]
 
 
2009-017869-27: A dual-center, open-label Proof of Concept study to evaluate the efficacy of Terguride for the treatment of fibrosis in patients with systemic sclerosis.

Ongoing
2
7
Europe
Terguride, PR1,
University Hospital Zurich
Diffuse scleroderma
 
 
paliperidone extended release / Generic mfg.
ChiCTR-IPR-16009208: The safety of Paliperidone Extended-Release Tablets and Olanzapine in treating patients with schizophrenia

Recruiting
4
120
 
Paliperidone Extended-Release Tablets ;Olanzapine
The Seventh People's Hospital of Shaoxing City; the seventh people’s hospital of Shaoxing City, the seventh people’s hospital of Shaoxing City
schizophrenia
 
 
NCT04478838: "Extended" (Alternate Day) Antipsychotic Dosing

Recruiting
4
120
Canada
Risperidone, Risperdal, Olanzapine, Zyprexa, Apo-Olanzapine, Sandoz-Olanzapine, Invega Paliperidone
Centre for Addiction and Mental Health
Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy, Antipsychotic Agents
09/27
09/28
2006-005734-20: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Flexible Dose Paliperidone ER in the Treatment of Subjects with Schizoaffective Disorder

Ongoing
3
40
Europe
Paliperidone ER, R076477,
Janssen L.P.
Schizoaffective disorder
 
 
ChiCTR-TRC-12002273: Effects of paliperidone extended-release tablets (paliperidone ER) and olanzapine on metabolic profile, insulin resistance and beta-cell function in schizophrenic patients: a randomized 12-week study

Completed
N/A
80
 
paliperidone extended-release ;olanzapine
First Affiliated Hospital, College of Medicine, Zhejiang University; Level of the institution:, Key Medical Disciplines Funds in Zhejiang Province
Schizophrenia
 
 
ChiCTR-TRC-14004854: A randomized, controlled, multi-center clinical trial to study the treatment resistant schizophrenia (TRS) in Zhejiang province

Completed
N/A
200
 
Paliperidone Extended-Release Tablets ;Olanzapine
First Affiliated Hospital, Zhejiang University School of Medicine; None, self-financing
Schizophrenia
 
 
ChiCTR-TRC-14004452: The efficacy and safety of Paliperidone Extended-Release Tablets combined with sodium valproate in Bipolar disorder manic episode

Recruiting
N/A
200
 
PANSS ;Paliperidone Extended-Release Tablets combined with placebo ;Paliperidone Extended-Release Tablets combined with sodium valproate
First Affiliated Hospital, College of Medicine, Zhejiang University; First Affiliated Hospital, College of Medicine, Zhejiang University, National Natural Science Foundation (81301158)
Bipolar disorder
 
 
quetiapine / Generic mfg.
2007-004513-33: Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression

Ongoing
4
300
Europe
Dispersible tablet, Tablet, Lamictal, TillVal Folysra (Folic acid)
University of Oxford
Bipolar depression
 
 
ChiCTR2200061843: A 24-Week, Randomized, Open-Label, Haloperidol-Control Study to Evaluate the Efficacy of Quetiapine in Improving Social Cognitive Function of Patients with Schizophrenia

Completed
4
62
 
treatment with quetiapine ;treatment with haliperidol
Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Xi’An Janssen Pharmaceutical Ltd.
Schizophrenia
 
 
ChiCTR-TNRC-10001112: The study on clinical and biological characters of bipolar depression and the treatment scheme optimizing

Completed
4
640
 
Lithium, Sodium valproate, Lamotrigine, MECT, Sertraline, Citalopram, Escitalopram, venlafaxine, Quetiapine, Olanzapine, Risperidone, sulpiride
Guangzhou Scientific and Technological Bureau, Guangzhou Board of Health; Guangzhou first people's hospital, The Tackling Key Problems of Guangzhou Scientific and Technological Project
bipolar depressive disorder
 
 
ChiCTR-TRC-10000934: Pharmacogenomic study of schizophrenia

Completed
4
3000
 
Perphenazine 16-64 mg/d (N=250) or Haloperidol 6-20 mg/d (N=250) ;Risperidone 2-6mg/d ;Olanzapine 5-20 mg/d ;Quetiapine 400-750mg/d ;Aripiperazole 10~30 mg/d ;Ziprasidone 80-160 mg/d
The Sixth Hospital / Institute of Mental Health, Peking University; The Ministry of Science and Technology, The National High Technology Research and Development Program of China (863 program)
Schizophrenia
 
 
ChiCTR-IPR-16009475: The research of chronic insomnia clinical evaluation and optimization of treatment

Completed
4
100
 
alprazolam ;Zolpidem ;Trazodone ;Quetiapine
Shanghai Mental Health Center; Shanghai Mental Health Center, Shanghai science and technology committee
chronic insomnia
 
 
2004-003826-92: \"A Randomized, Parallel Group, Open Trial Examining the Safety, Efficacy and Tolerability of Fast Titration, 800mg/day by day 4, of Quetiapine Fumarate Compared to Standard Titration, 400mg/day by day 4, in the Treatment of Bipolar 1 Manic Episode.\"

Ongoing
4
150
Europe
Fumarato de quetiapina (Seroquel), Seroquel 25 mg comprimidos recubiertos con película Seroquel 100 mg comprimidos recubiertos con película Seroquel 200 mg comprimidos recubiertos con película, Seroquel 25 mg comprimidos recubiertos con película Seroquel 100 mg comprimidos recubiertos con película Seroquel 200 mg comprimidos recubiertos con película
AstraZeneca Farmacéutica Spain, S.A.
Tratamiento del Episodio Maníaco Bipolar Tipo I
 
 
2004-005078-22: Quetiapin: Zur Sicherheit, Verträglichkeit und zum Einfluss auf kognitive Funktionen bei Patienten/innen mit einer schizophrenen Psychose Quetiapine: safety and influence on cognitive functions in patients with schizophrenia: a single-trial event-related potential analysis

Ongoing
4
15
Europe
Seroquel®, 47291.00.00, 47291.01.00, 47291.02.00, Seroquel®, Seroquel®
Medical School of Hannover
Patients with schizophrenia, who are not in an acute state of psychosis at enrolment (PANSS score < 80) and who do not show criteria of moderate depression, but may show depression-like symptoms corresponding to negative symptoms of schizophrenia (MADRS score ≤XXX). ICD classification code : F 20.0, 20.1, 20.2, 20.3, 20.5, 20.6
 
 
2004-002608-13: Pragmatic Randomised Control Trial of Quetiapine for psychosis in Parkinson’s Disease

Ongoing
4
60
Europe
Seroquel, Seroquel, Seroquel
King’s College London & King’s College Hospital
Parkinson\'s Disease with psychosis
 
 
2005-005072-32: Is it possible to modify the course of manic relapse? A pilot study of the effectiveness of quetiapine in preventing the development of manic episodes in Bipolar Disorder.

Ongoing
4
50
Europe
Quetiapine, Seroquel 100mg, Seroquel 150mg, Seroquel 200mg, Seroquel 300mg, Seroquel 100mg, Seroquel 150mg, Seroquel 200mg, Seroquel 300mg
Kings College London (IOP) / South London and Maudsley NHS Trust (Co-sponsorship)
Bipolar Disorder
 
 
2006-001317-15: BALANCE 2: Bipolar disorder:Antidepressant/Lamotrigine/ANtipsychotic Comparative Evaluation

Ongoing
4
630
Europe
Selective Serotonin Reuptake Inhibitors, SSRI, Quetiapine, Lamotrigine, Quetiapine, Lamotrigine
University of Oxford
Bipolar depression.
 
 
2006-002342-11: Multicenter study of neurotransmitters and neuropeptides in schizophrenia: A multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffering from schizophrenia treated with quetiapine (Seroquel®).

Ongoing
4
22
Europe
Seroquel 25, Seroquel 100, Seroquel 300, Seroquel 25, Seroquel 100, Seroquel 300, Seroquel 25, Seroquel 100, Seroquel 300
Klinikum Fulda gAG
Patients have to fulfill the diagnostic criteria of a schizophrenia according to DSM-IV.
 
 
2007-000579-40: Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study

Ongoing
4
34
Europe
Seroquel, Haloperidol Hexal, Seroquel, Haloperidol Hexal, Seroquel, Haloperidol Hexal
Charité Universitätsmedizin Berlin
Schizophrenia
 
 
2007-004528-19: Electrophysiological measurement of anterior cingulate cortex (ACC) function in schizophrenic patients treated with Seroquel® or Fluanxol®

Ongoing
4
50
Europe
Seroquel (Quetiapine), Fluanxol (Flupentixol), Seroquel, Fluanxol, Seroquel, Fluanxol
University of Wuerzburg
schizophrenia (295.10, 295.20, 295.30, 295.90 according to Diagnostic and Statistical Manual of Mental Disorders- Fourth Edition (DSM-IV)
 
 
2007-004897-26: Memantine for the Long Term Management of Neuropsychiatric Symptoms in Alzheimer\'s disease - MAIN-AD

Ongoing
4
300
Europe
Memantine, Risperidone, Ebixa, Risperdal, Zyprexa, Seroquel, Haloperidol (proprietary), Ebixa, Risperdal, Zyprexa, Seroquel, Haloperidol (proprietary)
King\'s College London, North Essex Partnership NHS Foundation Trust
Alzheimer\'s disease
 
 
2013-003460-31: The effect of low doses of mirtazapine and quetiapine on sleep and daytime functioning.

Ongoing
4
25
Europe
mirtazapine, quetiapine, n/a,
GGZ-Drenthe, GGZ-Drenthe
Insomnia
 
 
2016-001637-27: Lithium versus Quetiapine in Treatment Resistant Depression.

Ongoing
4
276
Europe
Lithium carbonate, Quetiapine, Lithium citrate, Tablet, Syrup
South London and Maudsley NHS Foundation Trust, King's College London, National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme
Treatment resistant major depressive disorder (single episode or recurrent). Treatment resistant depression, defined as failure to respond to two or more adequate doses of antidepressant in the current episode, Treatment resistant depression: where the person with depression has not responded adequately to two or more antidepressants given in the current episode of depression., Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
2017-002406-12: HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A study comparing continuation versus discontinuation/dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis HAMLETT. Handling Antipsychotic Medication: Lange termijn evaluatie van specifiek toegepaste medicatie. Vergelijking tussen het doorgaan met antipsychotische medicatie bij patiënten die hersteld zijn van eerste psychotische episode en vroegtijdig afbouwen/stoppen.

Not yet recruiting
4
512
Europe
RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE, CID5073, CID135398745, CID5002, CID60795, CID3559, CID5355, CID115237, CID16362, CID213046, CID135398737, CID2159, CID5467, CID60149, CID667467, CIS5311507, Tablet, RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE
University Medical Center Groningen, ZonMw
HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation. HAMLETT vergelijkt de reguliere behandeling van patiënten in remissie na een eerste psychotische episode zoals beschreven in de richtlijnen, namelijk het continueren van antipsychotica voor minstens 1 jaar, met het vroegtijdig afbouwen/stoppen met medicatie., HAMLETT compares continuation versus early discontinuation of antipsychotic medication in patients who have recovered from their first episode of psychosis. HAMLETT vergelijkt de reguliere behandeling van patiënten die hersteld zijn van een eerste psychose, namelijk minimaal 1 jaar antipsychotica gebruiken, met vroegtijdig afbouwen/stoppn met medicatie, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
2017-004602-17: Digital Medicine System

Not yet recruiting
4
60
Europe
DM-Aripiprazole, DM-Olanzapine, DM- Quetiapine, DM-Risperidone, Tablet, Aripiprazole, Olanzapine, Quetiapine, Risperidone
Otsuka Pharmaceutical, Otsuka Pharmaceutical
Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis, Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
ChiCTR1800014755: Study on individualized optimal treatment for antipsychotic drugs

Recruiting
4
2000
 
Risperidone ;Olanzapine ;Aripiperazole ;Quetiapine
国家科技部; Peking University Sixth Hospital, The Ministry of Science and Technology
Schizophrenia
 
 
LQD, NCT03004521: Lithium Versus Quetiapine in Treatment Resistant Depression

Recruiting
4
276
Europe
Quetiapine, Lithium
King's College London, University of Oxford, Newcastle University, Oxford Health NHS Foundation Trust, Northumberland, Tyne and Wear NHS Foundation Trust, South London and Maudsley NHS Foundation Trust, Tees, Esk and Wear Valleys NHS Foundation Trust, Sussex Partnership NHS Foundation Trust, Avon and Wiltshire Mental Health Partnership NHS Trust
Depressive Disorder, Treatment-Resistant
04/21
08/21
NCT04446234: Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building

Not yet recruiting
4
350
RoW
Risperidone, Aripiprazole, Ziprasidone, Amisulpride, Quetiapine
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine
Schizophrenia
12/22
12/22
NCT04513314: Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium

Withdrawn
4
20
NA
Valproate, Depakote, Valproic acid, Quetiapine, seroquel, Standard of Care, Hospital Protocol
University of Miami
Covid19, Hyperactive Delirium, Pneumonia, Viral
03/23
03/23
ChiCTR2100049426: A randomized and controlled study of ruracidone in the treatment of bipolar depression in adolescents and early adulthood

Not yet recruiting
4
60
 
treatment with lurasidone ;treatment with quetiapine
Beijing AnDing Hospital, Capital Medical University; Beijing AnDing Hospital, Capital Medical University, Beijing Hospital Authority
bipolar disorder
 
 
TraQ, NCT05085808: RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium

Not yet recruiting
4
30
US
Trazodone, Desyrel, Quetiapine, Seroquel, Placebo
University of Southern California
Delirium, Morality, Quality of Life, Psych, Treatment Side Effects
07/26
12/26
ChiCTR2200064086: The clinical efficacy of Quetiapine in the treatment of PD hallucinations and the mechanism of electrophysiology and brain imaging

Not yet recruiting
4
30
 
Quetiapine ;none ;none
Nanjing Brain Hospital; Nanjing Brain Hospital, crosswise tasks
Parkinson's disease with hallucinations
 
 
CAMELOT, NCT05590637: Comparing Antipsychotic Medications in LBD Over Time

Recruiting
4
94
US
Pimavanserin, Nuplazid, Quetiapine, Seroquel
The University of Texas Health Science Center at San Antonio, Alzheimer's Association
Parkinson's Disease Psychosis, Dementia With Lewy Bodies
08/25
02/26
NCT05741502: An Exploratory Analysis of Immune and Inflammatory Response Associated with Clozapine

Recruiting
4
60
US
Clozapine, Antipsychotics,Other (non-Clozapine), Including Olanzapine, Risperidone, Paliperidone, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, and all Typical antipsychotics
Ohio State University
Treatment-resistant Schizophrenia
03/26
06/26
NCT05737511: Efficacy of Hydroxyzine for Patients With Panic Disorder

Not yet recruiting
4
80
NA
Hydroxyzine, Atarax, Vistaril, Escitalopram Oxalate, citalopram, fluoxetine, fluvoxamine, paroxetine, paroxetine CR, sertraline, venlafaxine XR,, Alprazolam, clomipramine, clonazepam, diazepam, imipramine, lorazepam, mirtazapine, reboxetine, Bupropion SR, divalproex, duloxetine, gabapentin, levetiracetam, milnacipran, moclobemide, olanzapine, phenelzine, quetiapine, risperidone, tranylcypromine
Sultan Qaboos University
Panic Disorder
12/26
12/26
2005-003251-13: Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study

Ongoing
3
40
Europe
Seroquel, Seroquel 25 mg, Seroquel 100 mg, Seroquel 150 mg, Seroquel 200 mg, Seroquel 300 mg, Seroquel 25 mg, Seroquel 100 mg, Seroquel 150 mg, Seroquel 200 mg, Seroquel 300 mg
AstraZeneca UK Ltd
Depression
 
 
2009-011253-40: Paroxetine or Quetiapine in Addition to Mood Stabilizers in Bipolar Depression

Ongoing
3
40
Europe
DAPAROX*28CPR RIV 20MG PVC/PE/, SEROQUEL*60CPR RIV 100MG, DAPAROX*28CPR RIV 20MG PVC/PE/, SEROQUEL*60CPR RIV 100MG
AZIENDA SANITARIA OSPEDALIERA \"S. GIOVANNI BATTISTA DI TORINO\"
Major Depressive Episode in Bipolar Disorder
 
 
2010-021142-21: ?Alteraciones del sueño en pacientes con depresión mayor resistente al tratamiento con inhibidores selectivos de la recaptación de serotonina: ensayo clínico, aleatorizado, abierto, de grupos paralelos sobre la eficacia de Quetiapina de liberación prolongada vs Sales de Litio?

Ongoing
3
32
Europe
SEROQUEL PROLONG 50 mg comprimidos de liberación prolongada, PLENUR comprimidos de liberación modificada, SEROQUEL PROLONG 50 mg comprimidos de liberación prolongada, PLENUR comprimidos de liberación modificada
Fundación Institut de Recerca de l\' Hospital de la Santa Creu i Sant Pau
Depresión mayor resistente a Inhibidores Selectivos de la Recaptación de serotonina,Código de clasificación de la CIE : F-33
 
 
2016-004117-27: CONTROLLED, DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL FOR PROPHILAXIS OF POSOPERATIVE DELIRIUM IN HIGH RISK SURGICAL PATIENTS WITH QUETIAPINE. ENSAYO CLÍNICO CONTROLADO, DOBLE CIEGO Y ALEATORIZADO PARA LA PROFILAXIS CON QUETIAPINA DEL DELIRIO POSTOPERATORIO EN PACIENTES QUIRÚRGICOS DE RIESGO

Not yet recruiting
3
350
Europe
Capsule, Quetiapina NORMON 25 mg comprimidos recubiertos con peícula EFG
IBSAL (Instituto de Investigación Biomédica de, IBSAL, GRUPO DE RECUPERACION MULTIMODAL ESPAÑOL
Postoperative delirium in high risk surgical patients. Delirio postoperatorio en pacientes quirúrgicos de alto riesgo., Postoperative delirium. Delirio postoperatorio., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
NCT05690698: Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium

Completed
3
100
RoW
Quatiapine, Haloperidol
Alexandria University, Suez Canal University, Gezira University
Hyperactive Delirium
07/23
07/23
NCT06482554: Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Recruiting
3
80
US
Lumateperone 42 mg, Lumateperone, Risperidone 2 mg, olanzapine; quetiapine; ziprasidone; aripiprazole
Louisiana State University Health Sciences Center Shreveport
Apathy, Schizophrenia, Schizophrenia; Psychosis
12/26
12/26
NCT06333990: Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)

Recruiting
3
146
US
Quetiapine Fumarate, Seroquel, TAU, Treatment As Usual
Foundation for Advancing Veterans' Health Research, The University of Texas Health Science Center at San Antonio, Biomedical Research Institute of New Mexico
Mild Traumatic Brain Injury
06/28
06/28
INTENSIFY BD, NCT05973786: The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Recruiting
3
418
Europe
Escitalopram, ATC code: N06AB10, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04
Dr. Inge Winter, Universität Münster
Bipolar Depression
06/26
06/26
INTENSIFY, NCT05603104: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

Recruiting
3
1254
RoW
Clozapine, ATC code: N05AH02, Esketamine Nasal Product, ATC code: N06AB10, Escitalopram, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04, Second-line Antidepressants, Second-line Antipsychotics, Ketamine Hydrochloride, N01AX03, Esketamine hydrochloride, N015X14
Dr. Inge Winter, Universität Münster
Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression
06/26
06/26
2020-006062-36: A Phase II/III, randomized, 4-week, placebo-controlled study, designed to determine the safety, tolerability, and efficacy of evenamide (NW-3509) in patients with chronic schizophrenia.

Ongoing
2/3
196
Europe, RoW
Evenamide, NW3509, Capsule, hard
Newron Pharmaceuticals S.p.A., NEWRON PHARMACEUTICALS SPA, Newron Pharmaceuticals S.p.A, Newron Pharmaceuticals S.p.A., Newron Pharmaceuticals S.p.A
Chronic schizophrenia, Chronic schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
2021-001333-38: Clinical trial to study the effect of an already authorized drug on other pathologies by administering it to people with a recent diagnosis of schizophrenia. Ensayo clínico para estudiar el efecto que tiene un fármaco ya autorizado en otras patologías administrándolo en personas con reciente diagnóstico de esquizofrenia.

Not yet recruiting
2/3
50
Europe
VORTIOXETINA, HALOPERIDOL, Pimozida, Olanzapina, Risperidona, Chlorpromazine, Thioridazine, Quetiapine, Ziprasidone, aripiprazole, N06AX26, N05AD01, NO5AG02, NO5A H03, NO5AX08, N05AA01, N05AC02, N05AH04, N05AE04, N05AX12, Tablet, Capsule, hard, BRINTELLIX
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI), Consejería de salud
Early schizophrenia Esquizofrenia temprana, Newly evolving schizophrenia Esquizofrenia de reciente evolución, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
MEL-QUE, NCT06062953: Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients with Psychiatric Disorders and Comorbid Insomnia

Recruiting
2/3
255
Europe
Melatonin, Quetiapine, Placebo
Lone Baandrup, Danish Center for Sleep Medicine, Region Capital Denmark, Copenhagen Trial Unit, Center for Clinical Intervention Research, Mental Health Services in the Capital Region, Denmark
Psychiatric Disorders, Insomnia
02/29
02/29
ACTRN12622001532796: A multicentre, cluster randomised, double cross over pragmatic clinical trial comparing the safety and efficacy of enteral olanzapine with quetiapine in critically ill patients with hyperactive delirium

Not yet recruiting
2
1200
 
Royal Melbourne Hospital, The Australian and New Zealand Intensive Care Foundation
critical illness, hyperactive delirium
 
 
ACTRN12624001075572: A single centre pilot randomised controlled trial of enteral Guanfacine vs Quetiapine for agitated delirium in patients in the intensive care unit

Recruiting
2
36
 
Austin Hospital, Austin Health
Agitated delirium
 
 
2006-004783-31: A Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, MultiCentre, Phase IIa Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of AZD3480 in Schizophrenic Patients on Stable Antipsychotic Monotherapy with quetiapine, risperidone or olanzapine

Ongoing
2
50
Europe
AZD3480,
AstraZeneca AB
Schizophrenia
 
 
NCT05793632: Quetiapine in Prevention of Delirium

Completed
2
90
RoW
Quetiapine
Ain Shams University
Delirium
04/23
04/23
QOSA, NCT05303935: Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea

Completed
2
15
RoW
Quetiapine 50 MG, Seroquel, Placebo, Sugar pill
Flinders University
Sleep Apnea, Obstructive
04/23
04/23
NCT04521478 / 2019-004264-21: A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Completed
2
389
Europe, Canada, Japan, US, RoW
BI 1358894, Placebo, Quetiapine
Boehringer Ingelheim
Depressive Disorder, Major
01/24
02/24
NCT04280965: Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

Completed
1
28
US
Quetiapine Fumarate, Seroquel, Standard of care meducations
The University of Texas Health Science Center at San Antonio, South Central MIRECC
Post Traumatic Stress Disorder
04/22
10/22
NCT04950868: The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression

Active, not recruiting
1
22
Canada
Quetiapine
Verinder Sharma
Postpartum Depression
06/25
06/25
NCT05402111: A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

Completed
1
31
US
SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Schizophrenia
09/23
09/23
NCT05542264: A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

Completed
1
19
US
SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Schizophrenia
02/24
02/24
NCT05240261: Sleep Disorders in Chronic Kidney Disease Patients

Not yet recruiting
1
60
NA
Quetiapine
Assiut University
Chronic Kidney Diseases
05/24
12/24
NCT06546358: Quetiapine Versus Trazadone in Women With Postpartum Depression

Not yet recruiting
1
50
Canada
Trazodone, Teva-Trazadone, Quetiapine, Quetiapine Fumarate
Lawson Health Research Institute
Postpartum Depression
09/25
12/25
ChiCTR2100054147: Correlation between dopamine receptor gene polymorphism and clinical effect of bipolar depressive episode

Not yet recruiting
1
180
 
Lamotrigine ;Quetiapine ;Bupropion ;None
Jiaxing Kangci Hospital; Jiaxing Kangci Hospital, Provincial Health Commission, Jiaxing Kangci Hospital, self-funded
Bipolar depression
 
 
ChiCTR-TRC-14004814: A randomized controlled trial of repetitive transcranial magnetic stimulation combined with quetiapine in the first-episode bipolar II depressive episode

Completed
N/A
60
 
quetiapine+false TMS treatment ;quetaipine+rTMS high-frequency ;quetaipine+rTMS low-frequency
The First Affiliated Hospital, Zhejiang University; The First Affiliated Hospital, Zhejiang University, Scientific research expenses
Bipolar II depressive episode
 
 
ChiCTR-IPR-16008425: Efficacy of quetiapine in behavioral and psychological symptoms of Alzheimer's disease patients

Not yet recruiting
N/A
120
 
Quetiapine ;Memantine
Changning Mental Health Center; Changning Mental Health Center, Key program of the Changning Science and Technology Committee
Alzheimer's disease
 
 
ChiCTR-COC-17011401: A study of gut microbiota, immunology, Imageology in patients with bipolar disorder

Recruiting
N/A
200
 
quetiapine monotherapy
First Affiliated Hospital, Zhejiang University School of Medicine; First Affiliated Hospital, Zhejiang University School of Medicine, Provincial Natural Science Foundation
Bipolar disorder
 
 
NCT06200584: Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics

Completed
N/A
140
RoW
Risperidone, neuroleptics, Olanzapine, Quetiapine, Risperidone and Vitamin D and Vitamin E, vitamin, Olanzapine and Vitamin D and Vitamin E, Quetiapine and Vitamin D and Vitamin E
Dr Rabia Arshad
Antipsychotics and Neuroleptics Toxicity
06/21
06/21
NCT05098353: Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control

Recruiting
N/A
30
RoW
Quetiapine, Quetiapine - impulsivity
Federal Stare Budgetary Scientific Institution, Mental Health Research Center, Kazan State Medical University, Federal State Budgetary Institution V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, Saint-Petersburg, Russia
Bipolar Affective Disorder
11/21
12/21
NCT04209166: A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features

Recruiting
N/A
780
RoW
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors), SSRIs/SNRIs+Mood Stabilizer, SSRIs/SNRIs+Quetiapine, Usual Treatment
Shanghai Mental Health Center, Air Force Military Medical University, China, Guangzhou Psychiatric Hospital, Dalian Seventh People's Hospital, Wuhan Union Hospital, China, Shanghai Jiao Tong University School of Medicine
Major Depressive Disorder
10/22
10/22
SWITCH, NCT04312503: Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"

Completed
N/A
95
Europe
Lurasidone, Latuda, aripiprazole, olanzapine, quetiapine or risperidone
Aziende Chimiche Riunite Angelini Francesco S.p.A
Schizophrenia
10/22
10/22
ChiCTR2200059660: Clinical study of single intravenous injection of esmketamine combined with an oral antidepressant in the treatment of depressive disorde

Not yet recruiting
N/A
80
 
Use 0.25mg/kg ESM ketamine injection and physiological test Dilute saline injection to 50ml and drip intravenously for 40 minutes; Quetiapine fumarate (SRI Kang) was used as a synergist at a dose of 25-400 mg per day
Beijing Chaoyang Hospital; Beijing Chaoyang Hospital, self-raised
Depression
 
 
NCT05801289: Quetiapine as Prophylaxis for Delirium in CABG

Recruiting
N/A
60
RoW
Quetiapine, Seroquel
Ain Shams University
Delirium
04/23
04/23
NCT05840861: Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective Disorders

Recruiting
N/A
59
RoW
Vortioxetine, Quetiapine
Central South University
Major Depressive Disorder, Bipolar Disorder
08/23
09/23
NCT05833399: Correlation of Genetic Variations With Clinical Response in Substance Use Disorder

Recruiting
N/A
200
RoW
Quetiapine, olanzapine, mirtazapine, carbamazepine, sertraline, amitriptyline, chlorpromazine and risperidone, Seroquel, Olapex, Remeron, Tegretol, Moodapex, Tryptizol, Neurazine and Apexidone.
Alexandria University
Substance Use Disorders, Substance Dependence
03/24
12/24
ChiCTR2400083720: Effect of value orientation on brain activation in depressive patients with psychotic symptoms

Recruiting
N/A
60
 
Sertraline and quetiapine plus value-oriented short-term psychotherapy; Sertraline and quetiapine
The Second Affiliated Hospital of Xinxiang Medical College; The Second Affiliated Hospital of Xinxiang Medical College, Henan Province key research and development project
depression with psychotic symptoms
 
 
ChiCTR2100054169: Early effects of rTMS on bipolar depression by the modulation of prefrontal-amygdala/striatal brain network

Not yet recruiting
N/A
120
 
Combination therapy with rTMS and quetiapine ;Combination therapy with sham stimulation and quetiapine
Shenzhen Kangning Hospital; Shenzhen Kangning Hospital, Shenzhen Kangning Hospital
Bipolar depression
 
 
NCT06581302: Magnetic Seizure Therapy for Psychotic Disorders

Not yet recruiting
N/A
50
RoW
Magnetic seizure therapy by Magnetic stimulator, Seizure therapy, Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc), antipsychotics
Shanghai Jiao Tong University School of Medicine
Psychotic Disorders
12/25
12/25
PRHDTDCSTMDE, NCT05498441: Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive Episode

Recruiting
N/A
120
RoW
High-Definition Transcranial Direct Current Stimulation (HD-tDCS), Antipsychotics, mood stabilizers, etc.
Jiangsu Province Nanjing Brain Hospital
Major Depressive Episode
12/24
12/24
ChiCTR2300075440: Researches on the clinical curative effect of Yin-enching and Heat-cleaning on the treatment of the prodromal phases of bipolar disorder

Not yet recruiting
N/A
94
 
Traditional Chinese medicine formula granules+Imitated tablets of quetiapine fumarate; Chinese herbal placebo+quetiapine fumarate tablets
Beijing Anding Hospital,Capital Medical University; Beijing Anding Hospital,Capital Medical University, Beijing Municipal Administration of Hospital Incubating Program
the prodromal phases of bipolar disorder
 
 
TQDelirium, NCT05307003: Trazodone vs. Quetiapine for the Treatment of ICU Delirium

Recruiting
N/A
60
US
Trazodone, Desyrel, Quetiapine, Seroquel
University of Southern California
Delirium, Delirium of Mixed Origin, Delirium, Sepsis Associated, Delirium in Old Age, Delirium Confusional State, Psych, Morality, Treatment Side Effects
08/25
12/25
NCT04728581: Improving Sleep After TKA Using Mirtazapine and Quetiapine

Not yet recruiting
N/A
165
Europe
Mirtazapine, Quetiapine, Placebo
St. Anna Ziekenhuis, Geldrop, Netherlands
Osteo Arthritis Knee, Insomnia
05/26
01/27
NCT03449472: Bariatric Surgery and Pharmacokinetics of Quetiapine

Recruiting
N/A
12
Europe
Quetiapine, Quetiapine fumarate
Norwegian University of Science and Technology, St. Olavs Hospital, Volvat Medisinsk Senter Stokkan, Namsos Hospital, Alesund Hospital
Obesity, Morbid
10/26
10/26
CLASS-BD, NCT05480150: Chinese Longitudinal and Systematic Study of Bioplar Disorder

Recruiting
N/A
10000
RoW
Escitalopram Oxalate Tablets, Lexapro, Quetiapine Fumarate Tablets, Seroquel, Lurasidone, Latuda
First Affiliated Hospital of Zhejiang University
Major Depressive Disorder, Bipolar Disorder, Mixed, Affective; Disorder, Organic
12/26
12/26
ACTRN12616001227482: Thyroid tests in people who are taking quetiapine.

Recruiting
N/A
20
 
PathWest Laboratory Medicine, PathWest Laboratory Medicine
Mental health disorders, Schizophrenia, Bipolar disorder, Anxiety
 
 
ACTRN12616001242415: Thyroid tests in people who will be taking quetiapine.

Recruiting
N/A
20
 
PathWest Laboratory Medicine, PathWest Laboratory Medicine
Psychosis, treated with quetiapine, Mood disorders, treated with quetiapine, Agitation, treated with quetiapine
 
 
quetiapine extended-release / Generic mfg.
APQ-TRD, NCT04936126: Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression

Recruiting
4
150
RoW
Quetiapine, Amantadine, Pramipexole
All India Institute of Medical Sciences, Bhubaneswar, Indian Council of Medical Research
Treatment Resistant Depression
07/24
09/24
SMART-BD, NCT06433635: Sequential Multiple Assignment Randomized Trial for Bipolar Depression

Not yet recruiting
4
2726
Canada, US
Cariprazine, Vraylar, Aripiprazole/Escitalopram combination, Abilify/ Lexapro, Quetiapine, Seroquel, Lurasidone, Latuda
Massachusetts General Hospital, Patient-Centered Outcomes Research Institute
Bipolar I Disorder, Depression
02/30
02/30
C-SAPP, NCT04373317: Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Recruiting
4
358
US
Pimavanserin, Quetiapine
VA Office of Research and Development
Parkinson's Disease Psychosis
10/25
08/26
NCT03465787: A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia

Completed
3
210
RoW
Lurasidone HCL 160 mg, Quetiapine XR 600 mg
Bukwang Pharmaceutical
Schizophrenia
10/22
10/22
SEP361-304, NCT04115319 / 2019-002259-40: A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

Completed
3
475
Europe, US, RoW
SEP363856, quetiapine XR, Seroquel XR
Otsuka Pharmaceutical Development & Commercialization, Inc.
Schizophrenia
12/22
12/22
NCT04513912 / 2020-000341-14: A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Completed
3
757
Europe, Canada, US, RoW
Seltorexant, Matching placebo to Seltorexant, Quetiapine XR, Matching placebo to Quetiapine XR
Janssen Research & Development, LLC
Depressive Disorder, Major
10/23
10/23
ChiCTR2200066465: Bioequivalence of Quetiapine Fumarate Extended-release Tablets (Fasting /Feeding) in Healthy Human Body: a Randomized Cross-Over Controlled Trial

Not yet recruiting
1
40
 
In the morning of period I, participants received a single dose of test preparation after an overnight fast. In the period Ⅱ, participants crossed a single dose of reference preparation according to the randomized grouping table. ;In the morning of period I, participants received a single dose of reference preparation after an overnight fast. In the period Ⅱ, participants crossed a single dose of test preparation according to the randomized grouping table. ;In the morning of period I, participants received a single dose of test preparation after a high fat meal. In the period Ⅱ, participants crossed a single dose of reference preparation according to the randomized grouping table. ;In the morning of period I, participants received a single dose of reference preparation after a high fat meal. In the period Ⅱ, participants crossed a single dose of test preparation according to the randomized grouping table.
Xiangya Boai Rehabilitation Hospital; Europharm Laboratoires Co., Ltd., Europharm Laboratoires Co., Ltd.
Pharmacokinetics and Bioequivalence Study in human
 
 
NCT00710918: Quetiapine Compared With Placebo in the Management of Fibromyalgia

Recruiting
N/A
42
US
quetiapine, Seroquel XR, Placebo
East Tennessee State University Research Foundation
Fibromyalgia
06/11
12/11
mirtazapine / Generic mfg.
2006-003194-27: mirtazapine versus placebo in functional dyspepsia: a randomized, double-blind, placebo-controlled trial

Ongoing
4
60
Europe
mirtazapine, Orodispersible tablet, Remergon Soltab 15 mg
University Hospitals KU Leuven
functional dyspepsia diagnosed according to international consensus criteria ("Rome II criteria")
 
 
2009-016953-16: Depressions-Spektrums-Störung und differenzielle Effekte neuerer Antidepressiva auf die Verkehrssicherheit

Ongoing
4
120
Europe
Cipralex, Solvex, Remergil, Elontril, Valdoxan, Tablet, Cipralex, Solvex, Remergil, Elontril, Valdoxan
Inn-Salzach-Klinikum gGmbH
Spectrum of depressive diseases, ICD-10: F32.x, F33.x
 
 
ChiCTR-TRC-13003161: Clinical trials of antidepressant mirtazapine for the treatment of functional dyspepsia patients with weight loss

Completed
4
45
 
Group A is treated with conventional therapy during 8 weeks ;Group B is treated with conventional therapy in combination with Paroxetine during 8 weeks ;Group C is treated with conventional therapy in combination with Mirtazapine during 8 weeks
Guangzhou Nansha Central Hospital, Guangzhou First People's Hospital Affiliated to Guangzhou Medical College; Guangzhou Nansha Central Hospital, Guangzhou First People's Hospital Affiliated to Guangzhou Medical University, Self-funding
Functional Dyspepsia with Weight loss
 
 
2014-004862-89: The effect of mirtazapine (REMERGON®) an tetracyclic antidepressant on gastric movements and satiation in healthy subjects

Ongoing
4
30
Europe
mirtazapine, Film-coated tablet, REMERGON
KULeuven, KuLeuven
Functional Dyspepsia, the presence of dyspepsia in patients from which the cause of the gastric symptoms is unknown ( not organic nor metabolic), Diseases [C] - Digestive System Diseases [C06]
 
 
2004-002788-25: Hippocampal volume in young adults with moderate to severe depression before and after combined antidepressant therapy

Ongoing
4
160
Europe
Trevilor retard, Remergil Soltab, VENLA,
Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg
moderate to severe depression (episodes and recurrent diseases)
 
 
 

Download Options